期刊文献+

恩替卡韦片剂的质量比较研究 被引量:3

Comparative Study on Quality of Entecavir Tablets
原文传递
导出
摘要 目的研究恩替卡韦片剂的质量,为临床使用提供参考。方法收集原研、国内3家企业生产的恩替卡韦片剂,通过测定不同企业生产及不同批次的片剂溶出度、有关物质、含量均匀度和初步稳定性试验等数据,比较与评估各制剂的质量。结果国产A片剂的溶出度、有关物质和含量均匀度等指标均优于原研片和片剂C;A片剂在影响因素试验中,各项指标无显著差异,而原研片剂部分指标有波动;A片剂3年期内批间差异小。结论通过对所收集的4种恩替卡韦片剂质量数据分析表明,国产A片剂稳定性好,有延长产品有效期的基础。 OBJECTIVE To compare the quality between imported branded and 3 domestic entecavir tablets to provide references for clinical use. METHODS Tests of dissolution, content uniformity, related substances, influencing factor and preliminary stability were carried out between four products in batches, and the quality was compared and assessed. RESULTS Parameters of dissolution, content uniformity and related substances of entieavir tablet A were superior than that of branded product and C. Compared with imported branded tablets in inflencing factor tests, the quality of product A had no significant influence with high-quality during 3-year storage. CONCLUSION The quality of enticavir tablet A is noticebaly superior than branded and other domestic generic agents.
出处 《中国药学杂志》 CAS CSCD 北大核心 2015年第1期58-62,共5页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(81273469) 高等学校博士学科点专项科研基金(20110096110005) 江苏高校优势学科建设工程资助项目
关键词 恩替卡韦片剂 原研 仿制 质量 比较研究 entecavir tablet branded generic quality comparative study
  • 相关文献

参考文献7

  • 1ASHRAFALI M I, OM P S, MUTHUVEL S K, et al. Virological response and antiviral resistance mutations in chronic hepatitis B subjects experiencing entecavir therapy: An Indian subcontinent perspective [ J ]. Antiviral Res, 2013, 98 ( 2 ) : 209-216. 被引量:1
  • 2OSAMU Y, KOICHI T, SHINICHI F, et al. Long-term use of en- tecavir in nucleoside-na'fve Japanese patients with chronic hepatitis B infection [J]. J Hepatology, 2010, 52(6) :791-799. 被引量:1
  • 3陈琨,欧阳贵平,任志尧,汪春梅,杨金志.核苷类抗乙肝病毒药物研究最新进展及其合成方法[J].精细化工中间体,2008,38(2):16-22. 被引量:9
  • 4CHANG T T, GISH R G, ROBERT G G, et al. A Comparison of Entecavir and Lamivadine for HBeAg-Positive Chronic Hepatitis B [J]. New Eng JMed, 2006, 354(10) :1001-1010. 被引量:1
  • 5HIROYUKI Y, TAKAO S, HIROKI I, et al. Pooled model-based approach to compare the pharmacokinetics of entecavir between ap- anese and non-Japanese chronic hepatitis B patients [ J ]. Diagn Microbiol Infect Dis, 2011, 70( 1 ) : 91-100. 被引量:1
  • 6易毛,韩晋,吴素体,张诗龙,谢进,李正明,刘峰群,丁晋彪,楼金芳.HPLC法测定恩替卡韦分散片中恩替卡韦的含量[J].解放军药学学报,2012,28(6):520-522. 被引量:5
  • 7ABID M Y, JUN P J, SEUNG R H, et al. Development of direct compression entecavir 0. 5 mg-loaded tablet exhibiting enhaneed content uniformity[J]. Powder Technol, 2014, 267: 302-308. 被引量:1

二级参考文献11

共引文献12

同被引文献29

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部